Skip to content
10-Q

Quarterly Report

HYPERION THERAPEUTICS INC

0001193125-15-174481

← back to feed
Filed
May 6, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · Apr 30, 2015 20.98M sh
Shares Diluted Q1 2015 · Mar 31, 2015 22.08M sh
Shares Diluted Q1 2015 · Mar 31, 2014 21.52M sh
Capex Q1 2015 · Mar 31, 2015 $97K
Capex Q1 2015 · Mar 31, 2014 $29K
Cash And Equivalents Q1 2015 · Mar 31, 2015 $88.89M
Cash And Equivalents Q1 2015 · Dec 31, 2014 $102.8M
Cash And Equivalents Q1 2015 · Mar 31, 2014 $79.78M
Cash And Equivalents Q1 2015 · Dec 31, 2013 $74.23M
Stockholders Equity Q1 2015 · Mar 31, 2015 $140.18M
Stockholders Equity Q1 2015 · Dec 31, 2014 $131.55M
Current Liabilities Q1 2015 · Mar 31, 2015 $37.86M
Current Liabilities Q1 2015 · Dec 31, 2014 $30.4M
Total Liabilities Q1 2015 · Mar 31, 2015 $54.85M
Total Liabilities Q1 2015 · Dec 31, 2014 $48.86M
Current Assets Q1 2015 · Mar 31, 2015 $158.47M
Current Assets Q1 2015 · Dec 31, 2014 $159.4M
Total Assets Q1 2015 · Mar 31, 2015 $195.03M
Total Assets Q1 2015 · Dec 31, 2014 $180.42M
Eps Diluted Q1 2015 · Mar 31, 2015 $0.33
Eps Diluted Q1 2015 · Mar 31, 2014 $0.06
Eps Basic Q1 2015 · Mar 31, 2015 $0.35
Eps Basic Q1 2015 · Mar 31, 2014 $0.06
Sga Expense Q1 2015 · Mar 31, 2015 $14.98M
Sga Expense Q1 2015 · Mar 31, 2014 $11.17M
Rd Expense Q1 2015 · Mar 31, 2015 $6.8M
Rd Expense Q1 2015 · Mar 31, 2014 $3.22M
Net Income Q1 2015 · Mar 31, 2015 $7.22M
Net Income Q1 2015 · Mar 31, 2014 $1.26M
Operating Income Q1 2015 · Mar 31, 2015 $4.69M
Operating Income Q1 2015 · Mar 31, 2014 $1.7M
Cost Of Revenue Q1 2015 · Mar 31, 2015 $3.83M
Cost Of Revenue Q1 2015 · Mar 31, 2014 $2.38M
Revenue Q1 2015 · Mar 31, 2015 $31.19M
Revenue Q1 2015 · Mar 31, 2014 $19.48M